CANCER GENETICS, INC

Profile

Company Names

CANCER GENETICS, INC
CANCER GENETICS INC

Addresses

201 ROUTE17 NORTH, 2ND FLOOR, RUTHERFORD, NJ 07070

201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD, NJ 07070

Phone Numbers

201-528-9200
(201) 528-9200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$33,118,000.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-02-01 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
4
2017-03-22 
$6,000,000.00 
$6,000,000.00 
$0.00 
Debt 
3
2016-09-14 
$5,500,000.00 
$5,500,000.00 
$0.00 
 
2
2016-05-19 
$5,000,000.00 
$5,000,000.00 
$0.00 
 
1
2010-04-13 
$6,618,000.00 
$10,000,000.00 
$3,382,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDMUND 
 
CANNON 
DIRECTOR
CANCER GENETICS INC   |  CANCER GENETICS, INC
RAJU 
 
CHAGANTI 
EXECUTIVE OFFICER, DIRECTOR
CANCER GENETICS INC
RAJU 
S.K. 
CHAGANTI 
EXECUTIVE OFFICER, DIRECTOR
CANCER GENETICS, INC
RICCARDO 
 
DALLA-FAVERA 
DIRECTOR
CANCER GENETICS INC   |  RASNA THERAPEUTICS INC.
GEOFFREY 
 
HARRIS 
DIRECTOR
C7 LONG-SHORT FUND LP   |  MYND ANALYTICS, INC.   |  CANCER GENETICS, INC   |  CONNECTRN, INC.   |  OCELOT BIO, INC.   |  INSEER INC.
HOWARD 
 
MCLEOD 
DIRECTOR
CANCER GENETICS, INC
JOHN 
 
PAPPAJOHN 
DIRECTOR
PHARMATHENE, INC   |  SPECTRASCIENCE INC   |  CNS RESPONSE, INC.   |  CANCER GENETICS INC   |  GATE TECHNOLOGIES, LLC   |  ST. GREGORY CENTERS HOLDINGS, LLC   |  SYNCBAK, INC.   |  AMERICAN CARESOURCE HOLDINGS, INC.   |  MYND ANALYTICS, INC.   |  CANCER GENETICS, INC   |  CONNECTRN, INC.   |  INSEER INC.   |  ONERORX, INC.   |  TELEMYND, INC.
ANDREW 
 
PECORA 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  CANCER GENETICS INC   |  AMORCYTE INC   |  CELULARITY INC.   |  COTA, INC.   |  THIRD WAVE RECOVERY SYSTEMS, LLC
FRANKLYN 
G. 
PRENDERGAST 
DIRECTOR
ATIVA MEDICAL CORP   |  CANCER GENETICS, INC
JOHN 
A. 
ROBERTS 
EXECUTIVE OFFICER
CANCER GENETICS, INC
PANNA 
 
SHARMA 
EXECUTIVE OFFICER, DIRECTOR
CANCER GENETICS INC   |  LANTERN PHARMA INC.   |  LANTERN PHARMA
PANNA 
L. 
SHARMA 
EXECUTIVE OFFICER, DIRECTOR
CANCER GENETICS, INC
EDWARD 
 
SITAR 
EXECUTIVE OFFICER
CANCER GENETICS, INC
TOMMY 
 
THOMPSON 
DIRECTOR
SPECTRASCIENCE INC   |  CNS RESPONSE, INC.   |  CANCER GENETICS INC   |  CLEVELAND HEARTLAB, INC.   |  SANTA ROSA CONSULTING, INC.   |  SANTA ROSA HOLDINGS, LLC   |  LIFENEXUS, INC.   |  PROTECHSURE SCIENTIFIC, INC.   |  NEXERSYS CORP   |  SOCRATES HEALTH SOLUTIONS, INC.   |  US BIOLOGIC, INC.   |  LYOGENESIS HOLDINGS, LLC   |  VST OPERATING CORP.
MICHAEL 
J. 
WELSH 
DIRECTOR
CANCER GENETICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-02-03
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2021-02-01 
2017-03-27
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Debt 
2017-03-22 
2016-12-05
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
$5,000,001 - $25,000,000 
 
2016-09-14 
2016-05-25
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
$5,000,001 - $25,000,000 
 
2016-05-19 
2010-11-01
D/A
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2010-04-13 
2010-09-27
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2010-04-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
PORTFOLIO ADVISORS ALLIANCE, INC.
101680
GARDEN STATE SECURITIES, INC.
10083
NONE
NONE
FELIX INVESTMENTS, LLC
148441
PORTFOLIO ADVISORS ALLIANCE, INC.
101680
ALLEN PARTNERS
36518
PORTFOLIO ADVISORS ALLIANCE, INC.
101680
GARDEN STATE SECURITIES, INC.
10083